(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are VEON, ARRIBATEC GROUP, and ATLANTIC SAPPHIRE.

Financial Asset	Price	Change	Updated (EST)
VEON (VEON.AS)	0.73	18.51%	2023-09-13 12:04:59
ARRIBATEC GROUP (ARR.OL)	5.60	16.67%	2023-09-13 12:25:35
ATLANTIC SAPPHIRE (ASA.OL)	1.55	10.56%	2023-09-13 12:25:42
MITHRA (MITRA.BR)	2.22	9.63%	2023-09-13 12:20:54
AKER HORIZONS (AKH.OL)	4.59	5.42%	2023-09-13 12:25:20
HYBRID SOFTWARE GR (HYSG.BR)	3.50	5.42%	2023-09-13 12:20:11
BERGENBIO (BGBIO.OL)	0.12	4.82%	2023-09-13 12:26:00
SATS (SATS.OL)	11.92	4.2%	2023-09-13 12:43:16
GRIEG SEAFOOD (GSF.OL)	82.90	3.17%	2023-09-13 12:40:21
BELSHIPS (BELCO.OL)	17.30	3.1%	2023-09-13 12:25:58

The three biggest losers today are BIOSENIC, CELYAD ONCOLOGY, and XXL.

Financial Asset	Price	Change	Updated (EST)
BIOSENIC (BIOS.BR)	0.02	-18.44%	2023-09-13 12:05:54
CELYAD ONCOLOGY (CYAD.BR)	0.67	-8.97%	2023-09-13 12:06:09
XXL (XXL.OL)	0.64	-8.45%	2023-09-13 12:45:07
GEOJUNXION (GOJXN.AS)	0.82	-7.27%	2023-09-13 12:02:27
MKB Nedsense (NEDSE.AS)	0.10	-7.27%	2023-09-13 12:03:13
THUNDERBIRD (TBIRD.AS)	0.09	-7.22%	2023-09-13 12:04:33
ONWARD MEDICAL (ONWD.BR)	3.79	-6.88%	2023-09-13 12:21:14
MOREFIELD GROUP (MORE.AS)	0.31	-6.63%	2023-09-13 12:03:15
UNIFIEDPOST GROUP (UPG.BR)	2.68	-6.62%	2023-09-13 12:22:16
INTEROIL EXPL PROD (IOX.OL)	0.68	-5.82%	2023-09-13 12:40:44

Winners today

1. VEON (VEON.AS)

18.51% Price Change

VEON Ltd., together with its subsidiaries, provides mobile and fixed-line telecommunications services It offers voice, data, and other telecommunication services through a range of wireless, fixed, and broadband internet services. The company provides value-added services, including short messages, multimedia messages, caller number identification, call waiting, data transmission, mobile internet, downloadable content, mobile finance, machine-to-machine, and other services; national and international roaming services; wireless internet access; internet-TV services; digital and systems integration services; mobile financial services; and mobile bundles and call completion services. It offers value-added services for corporations, operators, and consumers, as well as sells equipment, infrastructure, and accessories. The company provides its services under the Beeline, Kyicvcstar, Jazz, Djezzy, and banglalink brands in Russia, Pakistan, Algeria, Uzbekistan, Ukraine, Bangladesh, Kazakhstan, Kyrgyzstan, and Georgia. The company was formerly known as VimpelCom Ltd. and changed its name to VEON Ltd. in March 2017. VEON Ltd. was founded in 1992 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with VEON jumping 18.51% to €0.73 on Wednesday, after two successive sessions in a row of gains. AEX-Index fell 0.24% to €734.93, after five consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

: VEON finalizes sale agreement to exit russian operationsI am pleased with the progress we have achieved in our exit from Russia despite the complexities of the transaction, said VEON Group CEO Kaan Terzioglu, in a statement.

Earnings Per Share

As for profitability, VEON has a trailing twelve months EPS of €0.26.

PE Ratio

VEON has a trailing twelve months price to earnings ratio of 2.81. Meaning, the purchaser of the share is investing €2.81 for every euro of annual earnings.

Volatility

VEON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.07%, a negative 0.18%, and a positive 2.16%.

VEON’s highest amplitude of average volatility was 2.80% (last week), 2.49% (last month), and 2.16% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VEON’s stock is considered to be oversold (<=20).

More news about VEON.

2. ARRIBATEC GROUP (ARR.OL)

16.67% Price Change

Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. The company was incorporated in 1998 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP rising 16.67% to €5.60 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.18% to €1,273.47.

Earnings Per Share

As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-1.38.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.

Volume

Today’s last reported volume for ARRIBATEC GROUP is 839375 which is 1298.82% above its average volume of 60006.

More news about ARRIBATEC GROUP.

3. ATLANTIC SAPPHIRE (ASA.OL)

10.56% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE jumping 10.56% to €1.55 on Wednesday, after five consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI fell 0.18% to €1,273.47, after three sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-4.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 1325580 which is 143.79% above its average volume of 543735.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

Moving Average

ATLANTIC SAPPHIRE’s worth is way below its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

More news about ATLANTIC SAPPHIRE.

4. MITHRA (MITRA.BR)

9.63% Price Change

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

BEL 20 ended the session with MITHRA jumping 9.63% to €2.22 on Wednesday, after three consecutive sessions in a row of losses. BEL 20 fell 0.64% to €3,640.71, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-1.22.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -176.58%.

Moving Average

MITHRA’s value is above its 50-day moving average of €2.16 and way below its 200-day moving average of €2.85.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MITHRA’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for MITHRA is 387225 which is 31.32% above its average volume of 294866.

More news about MITHRA.

5. AKER HORIZONS (AKH.OL)

5.42% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA is a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS jumping 5.42% to €4.59 on Wednesday while Oslo Børs Benchmark Index_GI slid 0.18% to €1,273.47.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-9.6.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Moving Average

AKER HORIZONS’s worth is way below its 50-day moving average of kr6.41 and way below its 200-day moving average of kr10.38.

More news about AKER HORIZONS.

6. HYBRID SOFTWARE GR (HYSG.BR)

5.42% Price Change

Hybrid Software Group PLC, together with its subsidiaries, develops software and hardware technology solutions for graphics and industrial inkjet printing in the United Kingdom, rest of Europe, North and South America, and Asia. The company offers Harlequin Core, a raster image processor (RIP) software that converts text and image data from various file formats, including PDF, TIFF, and JPEG files; ScreenPro, a software that converts tone image data into ready-to-print halftone in real-time; and Mako SDK, a software that creates, rasterizes, converts, analyses, and optimizes various page description languages, as well as allows print software developers to control over colour, fonts, text, images, vector content, and metadata. It also provides Harlequin Direct, a software that drives print data directly to the printer electronics instead of buffering them on mass storage devices; SmartDFE, a turnkey digital front end based on Harlequin Direct, CLOUDFLOW, and Meteor for digital printing of labels and packaging; Navigator Harlequin RIP and Workflow, a software that offers prepress environments to interpretation of PostScript, PDF, and EPS format files; Navigator DFE, a software that helps to prepare jobs, manage colour, and control digital output devices built with Memjet or any standard inkjet printhead; and Output Device Interfaces, a hardware and software solutions to connect RIPs to computer-to-plate devices, imagesetters, proofers, digital presses, high-speed copiers, and inkjet printers. The company was formerly known as Global Graphics PLC and changed its name to Hybrid Software Group PLC in October 2021. Hybrid Software Group PLC was founded in 1986 and is headquartered in Cambridge, the United Kingdom.

BEL 20 ended the session with HYBRID SOFTWARE GR rising 5.42% to €3.50 on Wednesday, after five consecutive sessions in a row of losses. BEL 20 fell 0.64% to €3,640.71, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, HYBRID SOFTWARE GR has a trailing twelve months EPS of €0.02.

PE Ratio

HYBRID SOFTWARE GR has a trailing twelve months price to earnings ratio of 175. Meaning, the purchaser of the share is investing €175 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.54%.

Yearly Top and Bottom Value

HYBRID SOFTWARE GR’s stock is valued at €3.50 at 22:40 EST, way below its 52-week high of €5.08 and above its 52-week low of €3.34.

Volume

Today’s last reported volume for HYBRID SOFTWARE GR is 6147 which is 171.75% above its average volume of 2262.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYBRID SOFTWARE GR’s stock is considered to be overbought (>=80).

Moving Average

HYBRID SOFTWARE GR’s value is way below its 50-day moving average of €3.91 and way below its 200-day moving average of €4.41.

More news about HYBRID SOFTWARE GR.

7. BERGENBIO (BGBIO.OL)

4.82% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 4.82% to €0.12 on Wednesday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.18% to €1,273.47, after three successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.74.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr0.12 at 22:40 EST, way under its 52-week high of kr13.03 and way higher than its 52-week low of kr0.08.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BERGENBIO’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for BERGENBIO is 24771600 which is 30.7% below its average volume of 35749800.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BERGENBIO’s EBITDA is -2.91.

More news about BERGENBIO.

8. SATS (SATS.OL)

4.2% Price Change

Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. The company offers sportswear, fitness gear, bars, and energy drinks. It operates 275 fitness clubs under the SATS, ELIXIA, Fresh Fitness, SATSonline and SATSYoga brands. The company was founded in 1995 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with SATS jumping 4.2% to €11.92 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.18% to €1,273.47.

Earnings Per Share

As for profitability, SATS has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.46%.

Moving Average

SATS’s worth is way higher than its 50-day moving average of kr10.83 and way higher than its 200-day moving average of kr9.44.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SATS’s stock is considered to be overbought (>=80).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 73.1% and 109.5%, respectively.

More news about SATS.

9. GRIEG SEAFOOD (GSF.OL)

3.17% Price Change

Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the production and sale of Atlantic salmon. The company was founded in 1884 and is headquartered in Bergen, Norway. Grieg Seafood ASA operates as a subsidiary of Grieg Aqua AS.

Oslo Børs Benchmark Index_GI ended the session with GRIEG SEAFOOD rising 3.17% to €82.90 on Wednesday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.18% to €1,273.47, after three successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr-3.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.47%.

Volume

Today’s last reported volume for GRIEG SEAFOOD is 359579 which is 71.29% above its average volume of 209915.

Earnings Before Interest, Taxes, Depreciation, and Amortization

GRIEG SEAFOOD’s EBITDA is 1.54.

More news about GRIEG SEAFOOD.

10. BELSHIPS (BELCO.OL)

3.1% Price Change

Belships ASA owns and operates dry bulk ships worldwide. It operates through Own Ships, Lighthouse Naviagtion, and Ship Management segments. The company operates a fleet of 34 Supra/Ultramax bulk carriers. It also provides commercial and ship management, technical, crewing, port agency, and logistical services. The company was founded in 1918 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with BELSHIPS jumping 3.1% to €17.30 on Wednesday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.18% to €1,273.47, after three sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, BELSHIPS has a trailing twelve months EPS of kr4.3.

PE Ratio

BELSHIPS has a trailing twelve months price to earnings ratio of 4.02. Meaning, the purchaser of the share is investing kr4.02 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.41%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 50.8%, now sitting on 614.13M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 42.5% and a negative 64.2%, respectively.

Volatility

BELSHIPS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.09%, a negative 0.13%, and a positive 1.44%.

BELSHIPS’s highest amplitude of average volatility was 0.88% (last week), 1.61% (last month), and 1.44% (last quarter).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 12, 2023, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 16.26%.

More news about BELSHIPS.

Losers Today

1. BIOSENIC (BIOS.BR)

-18.44% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC sliding 18.44% to €0.02 on Wednesday while BEL 20 slid 0.64% to €3,640.71.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €-0.02.

Volume

Today’s last reported volume for BIOSENIC is 714022 which is 112.42% above its average volume of 336128.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.72%, a negative 1.99%, and a positive 5.63%.

BIOSENIC’s highest amplitude of average volatility was 10.15% (last week), 6.19% (last month), and 5.63% (last quarter).

More news about BIOSENIC.

2. CELYAD ONCOLOGY (CYAD.BR)

-8.97% Price Change

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY sliding 8.97% to €0.67 on Wednesday, following the last session’s downward trend. BEL 20 dropped 0.64% to €3,640.71, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.48.

Volume

Today’s last reported volume for CELYAD ONCOLOGY is 14468 which is 58.08% below its average volume of 34518.

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.12%, a positive 1.82%, and a positive 4.24%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 7.50% (last week), 7.77% (last month), and 4.24% (last quarter).

More news about CELYAD ONCOLOGY.

3. XXL (XXL.OL)

-8.45% Price Change

XXL ASA operates as a sports retailer. It offers sports equipment and sportswear for various sports, including running, football, golf, water sports, racket sports, and ice hockey; and fitness equipment, including treadmills and rowing machines, as well as food supplements and nutrition. The company also provides clothes for men, women, and children for baselayers, outerwear, casual wear, sportswear, and swimwear, as well as lifestyle shoes and winter shoes; outdoor and hunting products for fishing, wilderness living, and camping, such as tents, lavvos, sleeping bags, backpacks, cooking equipment as well as climbing gear; and hunting products, including firearms and ammunition, clothes, binoculars, optics, knives, and axes. In addition, it offers skis and ski accessories, such as shoes, poles, clothes, and other equipment for cross-country and downhill skiing, as well as snowboarding; high-end and everyday bikes comprising hybrid bikes, mountain bikes, city bikes, and electric bikes for children, women, and men; and bike equipment, such as helmets, shoes, spare parts, and clothes. Further, the company provides products that connect technology and sports/outdoor activities, including sport watches, action cameras, drones, GPS, earplugs and headphones, portable loudspeakers, sunglasses, pulse meters, power banks, and cycle computers. It operates stores in Norway, Sweden, and Finland, as well as e-commerce websites, such as xxl.no, xxl.se, xxl.fi, and xxl.dk. The company was founded in 2000 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with XXL sliding 8.45% to €0.64 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI slid 0.18% to €1,273.47, after three sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, XXL has a trailing twelve months EPS of kr-1.73.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.05%.

Moving Average

XXL’s value is way under its 50-day moving average of kr1.54 and way below its 200-day moving average of kr2.84.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 200% and positive 33.3% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.9%, now sitting on 8.4B for the twelve trailing months.

More news about XXL.

4. GEOJUNXION (GOJXN.AS)

-7.27% Price Change

GeoJunxion N.V. manufactures and supplies digital maps, premium location content, and location intelligence services worldwide. The company provides location aware content products, including Digital Maps for use in routing, planning, and display services; Geo Location application programming interface (API) that addresses geocoding and time zones covering Europe and North America; and Geo Planning API, which provides time and distance matrices for logistics and resource planning applications, as well as premium location content products, such as Safety Alert Zone that concentrates on road safety by alerting mobility users; Eco Alert Zones, which includes dataset of regulated congestion, emission and restricted traffic zones for use in routing, planning, fleet management, display, real estate applications, and other sectors; and Health Alert Zones that contains COVID-19 related information. It also offers location intelligence services, which includes search and evaluation of location enabled content to enhance existing maps and/or routing applications; creating bespoke datasets; and producing outdoor venue plans for use in events, travel and tourism, real estate applications, last mile navigation and delivery, retail and distribution, and smart city applications, as well as operates GeoAlertsLive application. The company was formerly known as AND International Publishers N.V. GeoJunxion N.V. was founded in 1984 and is headquartered in Capelle aan den IJssel, the Netherlands.

AEX-Index ended the session with GEOJUNXION dropping 7.27% to €0.82 on Wednesday, following the last session’s downward trend. AEX-Index slid 0.24% to €734.93, after five successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, GEOJUNXION has a trailing twelve months EPS of €-0.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.12%.

More news about GEOJUNXION.

5. MKB Nedsense (NEDSE.AS)

-7.27% Price Change

MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense sliding 7.27% to €0.10 on Wednesday while AEX-Index slid 0.24% to €734.93.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.03%.

Yearly Top and Bottom Value

MKB Nedsense’s stock is valued at €0.10 at 22:40 EST, way below its 52-week high of €0.15 and way above its 52-week low of €0.09.

Volatility

MKB Nedsense’s last week, last month’s, and last quarter’s current intraday variation average was 0.63%, 0.01%, and 4.30%.

MKB Nedsense’s highest amplitude of average volatility was 3.17% (last week), 3.21% (last month), and 4.30% (last quarter).

Volume

Today’s last reported volume for MKB Nedsense is 1500 which is 87.68% below its average volume of 12183.

More news about MKB Nedsense.

6. THUNDERBIRD (TBIRD.AS)

-7.22% Price Change

Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.

AEX-Index ended the session with THUNDERBIRD dropping 7.22% to €0.09 on Wednesday, after three sequential sessions in a row of losses. AEX-Index slid 0.24% to €734.93, after five consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.01.

PE Ratio

THUNDERBIRD has a trailing twelve months price to earnings ratio of 9. Meaning, the purchaser of the share is investing €9 for every euro of annual earnings.

Volatility

THUNDERBIRD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.62%, a negative 0.67%, and a positive 4.29%.

THUNDERBIRD’s highest amplitude of average volatility was 2.65% (last week), 2.30% (last month), and 4.29% (last quarter).

More news about THUNDERBIRD.

7. ONWARD MEDICAL (ONWD.BR)

-6.88% Price Change

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

BEL 20 ended the session with ONWARD MEDICAL sliding 6.88% to €3.79 on Wednesday, after two sequential sessions in a row of losses. BEL 20 slid 0.64% to €3,640.71, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.44%.

More news about ONWARD MEDICAL.

8. MOREFIELD GROUP (MORE.AS)

-6.63% Price Change

Morefield Group N.V. through its subsidiary Kersten Groep BV, engages in the selecting, advising, supplying, and maintaining medical aids for physical disability peoples. The company also manufactures orthoses, such as braces and splints. It serves to municipalities, care administration offices, health insurers, and care institutions/care organizations. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. was incorporated in 1983 and is headquartered in Willemstad, Curaçao.

AEX-Index ended the session with MOREFIELD GROUP dropping 6.63% to €0.31 on Wednesday, following the last session’s upward trend. AEX-Index slid 0.24% to €734.93, after five sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.1.

PE Ratio

MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 3.1. Meaning, the purchaser of the share is investing €3.1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.06%.

Volume

Today’s last reported volume for MOREFIELD GROUP is 3500 which is 63.6% below its average volume of 9617.

Yearly Top and Bottom Value

MOREFIELD GROUP’s stock is valued at €0.31 at 22:40 EST, way under its 52-week high of €0.38 and way higher than its 52-week low of €0.27.

Moving Average

MOREFIELD GROUP’s worth is above its 50-day moving average of €0.31 and above its 200-day moving average of €0.30.

More news about MOREFIELD GROUP.

9. UNIFIEDPOST GROUP (UPG.BR)

-6.62% Price Change

UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with UNIFIEDPOST GROUP dropping 6.62% to €2.68 on Wednesday, after four consecutive sessions in a row of losses. BEL 20 fell 0.64% to €3,640.71, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.78%.

Volume

Today’s last reported volume for UNIFIEDPOST GROUP is 152286 which is 771.45% above its average volume of 17475.

More news about UNIFIEDPOST GROUP.

10. INTEROIL EXPL PROD (IOX.OL)

-5.82% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD sliding 5.82% to €0.68 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI fell 0.18% to €1,273.47, after three sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr-0.34.

Yearly Top and Bottom Value

INTEROIL EXPL PROD’s stock is valued at kr0.68 at 22:40 EST, way under its 52-week high of kr1.29 and way higher than its 52-week low of kr0.52.

Volatility

INTEROIL EXPL PROD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.29%, a negative 0.25%, and a positive 2.53%.

INTEROIL EXPL PROD’s highest amplitude of average volatility was 6.91% (last week), 4.34% (last month), and 2.53% (last quarter).

More news about INTEROIL EXPL PROD.

Stay up to date with our winners and losers daily report